Sheila Woodhouse MD, MBA, Facc
About Sheila Woodhouse MD, MBA, Facc
Sheila Woodhouse MD, MBA, FACC, is the Senior Director and Digital Health Lead for Global Drug Development at Bristol Myers Squibb, and a practicing cardiologist in the Maryland and Washington D.C. Metro area.
Senior Director at Bristol Myers Squibb
Sheila Woodhouse MD, MBA, Facc holds the role of Senior Director, Digital Health Lead, Global Drug Development at Bristol Myers Squibb. She operates primarily out of Princeton, New Jersey, and Washington D.C. In this capacity, she is responsible for spearheading digital health initiatives within global drug development.
Cardiologist in Maryland and Washington DC Metro
Sheila Woodhouse currently practices both inpatient and outpatient cardiology in the Maryland and Washington DC metro areas. This role encompasses a wide array of responsibilities including patient care, diagnosis, and treatment of cardiovascular diseases.
Clinical Advisory Role at Digital Therapeutics Alliance
Sheila Woodhouse is involved with the Digital Therapeutics Alliance as a member of their Clinical Advisor Group. In this role, she provides clinical insights and expertise to support the alliance's efforts in advancing digital therapeutic solutions.
Leadership at Sentikon Technologies and Optimano Technology
She currently leads Sentikon Technologies & Consulting, LLC and Optimano Technology LLC as the President & Principal Healthcare Technology and Analytic Consultant. Located in the Greater Atlanta Area and Washington DC, these roles involve guiding technological and analytical healthcare solutions.
Previous Role at University of Maryland Medical System
From 2020 to 2022, Sheila Woodhouse served as a Cardiologist and the Medical Director of the Cardiology Department and CV Ambulatory Research at the University of Maryland Medical System in National Harbor, MD. Her role was pivotal in overseeing the cardiology department and contributing to ambulatory research initiatives.
Education and Certification in Healthcare Analytics
Sheila Woodhouse obtained her Healthcare Analytics Certification from the University of Washington where she studied Health Care Analytics from 2018 to 2019. Additionally, she holds a Bachelor's Degree in Biochemistry from Carnegie Mellon University, an MBA from Georgia State University - J. Mack Robinson College of Business, and an MD from Temple University - Lewis Katz School of Medicine.
Experience at Emory Healthcare
She worked as a Cardiovascular Disease Specialist at Emory Healthcare from 2012 to 2017 in Gwinnett Lawrenceville, Atlanta Metro, providing comprehensive cardiovascular care and treatment during her five-year tenure.
Founder and CEO of DoxMed
Sheila Woodhouse is the founder of DoxMed, where she served as CEO for a decade from 2000 to 2010 in Atlanta. DoxMed focuses on bringing innovative healthcare solutions and services to market.